Chamomile for sleep and generalized anxiety - where it helps and where it doesn't

Chamomile is one of the most commonly used medicinal plants in the world, but for centuries it was regarded as a "grandmother's remedy" without solid scientific evidence. This has changed in the last decade. A meta-analysis of 12 RCT studies from 2019 showed that standardized chamomile extract (Matricaria chamomilla) significantly reduced anxiety symptoms and improved sleep quality compared to placebo, with effects lasting throughout the supplementation period (Hieu et al., PMC, 2019). The mechanism is well understood - apigenin, the main flavonoid in chamomile, binds to GABA-A receptors in the brain, the same system that sedative medications act on. This article answers where chamomile truly works and where its reputation outpaces the evidence.

KEY INFORMATION
• A meta-analysis of 12 RCTs showed that chamomile extract significantly reduces anxiety symptoms and improves sleep quality vs placebo (Hieu et al., PMC 2019).
• Mechanism: apigenin binds to GABA-A receptors - the same system as benzodiazepines, but weaker and without the risk of addiction.
• The effect on generalized anxiety (GAD) was clinically significant in a study from the University of Pennsylvania (2009) after 8 weeks of supplementation.
• Chamomile does not replace psychiatric treatment for severe disorders - it is a supplement, not a medication.

Apigenin and GABA-A receptors - how chamomile affects the brain

The key active ingredient in chamomile responsible for its calming and sleep-inducing effects is apigenin - a flavonoid primarily found in the flowers. Matricaria chamomilla. Apigenin binds to benzodiazepine binding sites on GABA-A receptors - the same receptors through which diazepam, lorazepam, and other sedative medications act. GABA (gamma-aminobutyric acid) is the main inhibitory neurotransmitter in the central nervous system; enhancing its action through apigenin reduces neuronal excitability and facilitates falling asleep.

The difference between apigenin and benzodiazepines is quantitative and selective: apigenin binds to GABA-A receptors with 10-100 times lower affinity than classic benzodiazepines and shows selectivity for specific receptor subtypes (α1, α2), which explains the weaker anxiolytic effect without the risk of addiction. Studies on animal models have demonstrated a clear anxiolytic effect of apigenin without tolerance or dependence symptoms after long-term use (Viola et al., PubMed, 1995).

What do clinical studies say about chamomile for anxiety?

A groundbreaking clinical study published by Mao et al. from the University of Pennsylvania (2009) included 57 patients diagnosed with generalized anxiety disorder (GAD). For 8 weeks, they received standardized chamomile extract (270 mg/day, 1.2% apigenin) or placebo. Result: significant reduction in GAD symptoms on the HAM-A scale (Hamilton Anxiety Rating Scale) in the chamomile group vs. placebo - clinically significant difference (Mao et al., PMC, 2009).

Importantly, the same study had an extension - a 26-week continuation phase (2016) showed that long-term chamomile supplementation reduced the risk of symptom relapse in GAD after therapy ended, without withdrawal symptoms when gradually reducing the dose. This favorably distinguishes chamomile from benzodiazepines, where withdrawal after long-term use is a serious clinical issue.

Chamomile for sleep - what does research show?

A 2017 RCT evaluated the effect of chamomile extract on sleep quality in 60 older adults (60+) with insomnia. Participants took 200 mg of extract twice daily for 28 days. Results: significant improvement in sleep quality (measured by the PSQI - Pittsburgh Sleep Quality Index), shorter time to fall asleep, and reduced number of nighttime awakenings compared to the placebo group. The effects persisted throughout the study period, and no tolerance was observed (Hieu et al., PMC 2019).

The sleep-inducing mechanism is linked to the same GABA-A system, but in older adults with insomnia, the effect may be stronger than in young adults, as aging is associated with reduced activity of the GABAergic system. Chamomile does not cause "narcosis" - it does not shut down consciousness like a sleeping pill. It works subtly: shortening the time to fall asleep, reducing nighttime arousal, and improving subjective sleep quality while maintaining the natural architecture of sleep (NREM and REM phases).

We have noticed that many people drink chamomile tea once before bed and are disappointed by the lack of effect. Meanwhile, clinical studies have shown effects after 14-28 days of regular use, not after one cup. Chamomile works cumulatively - apigenin must reach a stable tissue concentration to modulate GABA-A receptor reactivity. One-time chamomile tea may provide a placebo effect or minimal effect - systematic use over several weeks yields documented results.

Where chamomile does not work - limits of effectiveness

Chamomile is not a medication and does not replace psychiatric treatment. Severe anxiety disorders (GAD with significant functional impairment), panic disorders, social phobia with intense avoidance, PTSD, or depression with an anxiety component require psychiatric evaluation and, if indicated, pharmacotherapy or psychotherapy (CBT). Chamomile can be a valuable complement to therapy, but it does not replace it in serious disorders.

Organic insomnia - related to sleep apnea, restless legs syndrome, chronic pain, or circadian rhythm disorders - will not respond to apigenin, as its cause does not lie in the activity of GABA-A receptors. Chamomile is effective for functional insomnia (related to tension, anxiety, difficulties in calming down before sleep), not for organic insomnia requiring diagnosis and causal treatment.

Allergy to Asteraceae is an important contraindication - the Asteraceae family includes not only chamomile but also ragweed, ambrosia, marigolds, and daisies. Cross-reactions between these plants are well documented: if you are allergic to grass pollen or ragweed, the risk of a reaction to chamomile is significantly higher. According to the European Medicines Agency (EMA) monograph for Matricaria chamomilla, chamomile is absolutely contraindicated in hypersensitivity to Asteraceae - also in the form of tea and oral extracts, not just preparations used on the skin.

Frequently Asked Questions

Does chamomile really help you sleep?

Yes, but the effect is moderate and cumulative. RCT showed a significant improvement in sleep quality and a reduction in sleep onset time after 28 days of taking 200-270 mg of extract daily (Hieu et al., PMC 2019). The mechanism works through apigenin binding to GABA-A receptors. A single tea provides minimal effect - regular use for 2-4 weeks yields documented results.

Does chamomile help with generalized anxiety disorder (GAD)?

Yes - this is one of the better-documented effects. An RCT study (Mao et al., PMC 2009) showed a clinically significant reduction in GAD symptoms on the HAM-A scale after 8 weeks of supplementation with 270 mg/day of extract. A long-term study (2016) confirmed a reduced risk of symptom relapse after discontinuation, without signs of dependence.

How much chamomile tea do you need to drink to feel the effect?

Studies used extracts of 270-400 mg/day, which corresponds to strongly brewed tea made from 2-3 g of dry flowers (10-15 minutes of brewing) consumed 30-60 minutes before sleep. One weak tea bag provides a lower dose of apigenin. The effect is noticeable after 2-4 weeks of regular use - not after a single use.

Can chamomile be addictive like benzodiazepines?

No. Apigenin binds to GABA-A receptors significantly weaker and more selectively than benzodiazepines. A 26-week study showed no tolerance or withdrawal symptoms (Mao et al., 2016). Chamomile does not lead to physical dependence - this is a fundamental difference from clinically used sedative medications.

Who will not benefit from chamomile?

Chamomile cannot replace psychiatric treatment for severe anxiety disorders, depression, or organic insomnia (sleep apnea, restless legs syndrome). Individuals allergic to Asteraceae (mugwort, ragweed, marigolds) should avoid it - confirmed cross-reactivity. Not recommended during pregnancy (potential oxytocin-like effects, insufficient safety data).

Does chamomile interact with medications?

Yes. Apigenin and coumarins can inhibit CYP1A2 and CYP2C9, interacting with warfarin (risk of bleeding). Chamomile may enhance the effects of sedatives and sleeping pills (risk of excessive sedation). Consult your doctor when taking any medications before regular supplementation.

What form of chamomile is the most effective?

Capsules with standardized extract (270-400 mg, 1.2% apigenin) have the best-documented clinical effects - they provide a repeatable dose of apigenin. Tea made from 2-3 g of dry flowers (10-15 minutes of brewing) is effective with regular use. Ethanol tincture has good bioavailability, but fewer clinical studies.

Does chamomile help with anything besides sleep and anxiety?

Yes - it has documented anti-inflammatory effects (inhibition of COX-2 and NF-κB by apigenin and bisabolol), alleviates gastrointestinal discomfort (cramps, IBS - moderate evidence) and reduces skin irritations (chamomile ointment comparable to 0.25% hydrocortisone in dermatological studies). Evidence for these applications is weaker than for sleep and anxiety.

This article is for informational and educational purposes and does not replace consultation with a doctor. If you are pregnant, breastfeeding, taking medications, or have chronic conditions, consult the use of supplements or herbs with a specialist.

Author: Michał Waluk · Published: 2026-05-04 · Updated: 2026-05-04